← FDA DRUG APPROVALS

FDA ANDA · ANDA078203

LORAZEPAM

Sponsor: LEADING

APPLICATION
ANDA078203
TYPE
ANDA
ORIGINAL APPROVAL
2007-07-30
LATEST ACTION
2007-07-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

LORAZEPAMPrescription
LORAZEPAM 2MG · TABLET · ORAL
LORAZEPAMPrescription
LORAZEPAM 0.5MG · TABLET · ORAL
LORAZEPAMPrescription
LORAZEPAM 1MG · TABLET · ORAL

Approval history

2007-07-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →